Treating Reproductive-Aged Women With Glucagon-Like Peptide-1 Receptor Agonists: What Are the Clinical Considerations?

被引：0
作者：
Sharma, Garima [1 ]
机构：
[1] Inova Hlth Syst, Inova Schar Heart & Vasc, 8081 Innovat Pk Dr,7th Fl,700, Fairfax, VA 22031 USA
来源：
CIRCULATION | 2024年 / 150卷 / 19期
关键词：
cardiovascular-kidney-metabolic; GLP-RA; obesity; pregnancy;
D O I：
10.1161/CIRCULATIONAHA.124.070766
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1487 / 1489
页数：3
相关论文
共 50 条
[21]   Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease [J].
Anderson, Scott R. ;
Ayoub, Malek ;
Coats, Sarah ;
McHenry, Scott ;
Tan, Tingyi ;
Deepak, Parakkal .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (05) :1152-1155
[22]   Impact of glucagon-like peptide-1 receptor agonists on hypertension management: a narrative review [J].
De Oliveira-Gomes, Diana ;
Pingili, Adhvithi ;
Inglis, Sara ;
Mandras, Stacy A. ;
Loro-Ferrer, Juan F. ;
daSilva-deAbreu, Adrian .
CURRENT OPINION IN CARDIOLOGY, 2025, 40 (04) :185-192
[23]   The current and changing role of glucagon-like peptide-1 receptor agonists in knee osteoarthritis [J].
Holleman, Anne D. ;
Katz, Jeffrey N. .
OSTEOARTHRITIS AND CARTILAGE OPEN, 2025, 7 (03)
[24]   Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence [J].
Kaplan, Alan G. ;
Kim, James W. .
PULMONARY THERAPY, 2022, 8 (04) :343-358
[25]   Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity [J].
Burcelin, R. ;
Gourdy, P. .
OBESITY REVIEWS, 2017, 18 (01) :86-98
[26]   Glucagon-like Peptide-1 Receptor Agonists: Exciting Avenues Beyond Weight Loss [J].
Sundararaman, Lalitha ;
Gouda, Divakara ;
Kumar, Anil ;
Sundararaman, Sumithra ;
Goudra, Basavana .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
[27]   Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL [J].
Torekov, Signe Sorensen .
CARDIOVASCULAR RESEARCH, 2018, 114 (10) :E70-E71
[28]   The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease [J].
Tsiampali, Chara ;
Papaioannidou, Paraskevi ;
Goulas, Antonis ;
Polyzos, Stergios A. .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (11) :1063-1072
[29]   Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging signal? [J].
Lau, Darren ;
Gamble, John-Michael .
DIABETES OBESITY & METABOLISM, 2024, 26 (04) :1150-1156
[30]   Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus A Role in Cardiovascular Disease [J].
Smilowitz, Nathaniel R. ;
Donnino, Robert ;
Schwartzbard, Arthur .
CIRCULATION, 2014, 129 (22) :2305-2312
12345